Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Alzheimer's type dementia: recent data].

Y Lamour, P Davous

    Presse Medicale (Paris, France : 1983)
    |May 21, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Alzheimer type dementia (DTA) is a growing public health concern. Neurochemical deficits, particularly in the cholinergic system, offer targets for new therapeutic trials.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A prospective study of depression in French patients with Parkinson's disease. The Depar study.

    European journal of neurology·2013
    Same author

    [Facial diplegia and acute inflammatory demyelinating neuropathy secondary to varicella].

    Revue neurologique·2008
    Same author

    [Fragile X premutation presenting as postural tremor and ataxia (FXTAS syndrome)].

    Revue neurologique·2007
    Same author

    [Apolipoprotein E and bleomycin hydrolase. Polymorphisms: association with neurodegenerative diseases].

    Annales de biologie clinique·2003
    Same author

    [Atypical CADASIL phenotypes and pathological findings in two new French families].

    Revue neurologique·2001
    Same author

    [Tuberculous meningitis in an immunocompetent adult: contribution of cerebral imaging techniques to the diagnosis and follow-up].

    Revue neurologique·1999
    Same journal

    Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

    Presse medicale (Paris, France : 1983)·2026
    Same journal

    Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

    Presse medicale (Paris, France : 1983)·2026
    Same journal

    AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

    Presse medicale (Paris, France : 1983)·2026
    Same journal

    Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

    Presse medicale (Paris, France : 1983)·2026
    Same journal

    Ethical, legal, and regulatory challenges in AI-based healthcare tools.

    Presse medicale (Paris, France : 1983)·2026
    Same journal

    Decision-making for clinicians.

    Presse medicale (Paris, France : 1983)·2026
    See all related articles

    Area of Science:

    • Neurology
    • Neuroscience
    • Geriatrics

    Context:

    • Alzheimer type dementia (DTA) is the most prevalent form of adult-onset dementia.
    • Increasing prevalence due to aging populations presents a significant public health challenge.
    • Characterized by progressive memory loss, cognitive decline, and behavioral changes.

    Purpose:

    • To review the histopathological and neurochemical features of DTA.
    • To discuss current hypotheses regarding DTA etiology.
    • To highlight the potential for targeted therapeutic interventions based on neurochemical deficits.

    Summary:

    • DTA involves characteristic brain lesions including neurofibrillary tangles and senile plaques.
    • Postmortem studies reveal consistent reductions in neurotransmitter-synthesizing enzymes, notably choline acetyltransferase, indicating a cholinergic deficit.

    Related Experiment Videos

  • Other neurotransmitter systems, such as noradrenaline and somatostatin, may also be affected.
  • Various etiological hypotheses, including genetic, viral, toxic, immunologic, and metabolic factors, are under investigation.

    • Impact:

    • Understanding DTA's neurochemical underpinnings is crucial for developing effective treatments.
    • The identification of specific neurotransmitter deficits supports the development of targeted therapeutic strategies.
    • Advances in DTA research can improve patient outcomes and quality of life.